POST-ACUTE COVID-19

Clinical trials for POST-ACUTE COVID-19 explained in plain language.

Never miss a new study

Get alerted when new POST-ACUTE COVID-19 trials appear

Sign up with your email to follow new studies for POST-ACUTE COVID-19, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

New drug trial targets lingering COVID breathing woes

Disease control Recruiting now

This trial is testing if a drug called anakinra can help people with long COVID who have ongoing breathing problems and signs of an overactive immune system. About 182 participants will be randomly assigned to receive either anakinra or a placebo for 4 to 8 weeks. The main goal i…

Matched conditions: POST-ACUTE COVID-19

Phase: PHASE2, PHASE3 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

POST-ACUTE COVID-19

Get alerted when new POST-ACUTE COVID-19 trials appear

New drug trial targets lingering COVID breathing woes